Pfizer recalls Levoxyl (levothyroxine sodium tablets
- Published
- 20 Aug 2025
- Units affected
- 29, 004 bottles
- Agency
- FDA
- Country
- United States
The hazard
Subpotent drug
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
- Brand / company
- Pfizer
- Codes / lots
- Lot #: 24C11, Exp 2/28/2026.
- Distribution
- Within U.S
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 20 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.